SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Danilo Villalta, Maria Concetta Sorrentino, Elia Girolami, Marilina Tampoia, Maria Grazia Alessio, Ignazio Brusca, Massimo Daves, Brunetta Porcelli, Giuseppina Barberio, Nicola Bizzaro, Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay, Clinica Chimica Acta, 2015, 438, 135

    CrossRef

  2. 2
    Yun-A Jo, Mi Young Kim, Han-Sung Kim, Young Kyung Lee, Hee Jung Kang, Jong Hyeok Kim, A Comparative Evaluation of the Performances of Anti-MIT3, Anti-gp210, and Anti-sp100 Antibodies for the Diagnosis of Primary Biliary Cirrhosis, Laboratory Medicine Online, 2014, 4, 2, 91

    CrossRef

  3. 3
    Gary L. Norman, Chen-Yen Yang, Heather P. Ostendorff, Zakera Shums, Mark J. Lim, Jinjun Wang, Amany Awad, Gideon M. Hirschfield, Piotr Milkiewicz, Donald B. Bloch, Kenneth J. Rothschild, Christopher L. Bowlus, Iannis E. Adamopoulos, Patrick S.C. Leung, Harry J. Janssen, Angela C. Cheung, Catalina Coltescu, M. Eric Gershwin, Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis, Liver International, 2014, 34, 10
  4. 4
    Frans J.C. Cuperus, Emina Halilbasic, Michael Trauner, Fibrate treatment for primary biliary cirrhosis, Current Opinion in Gastroenterology, 2014, 30, 3, 279

    CrossRef

  5. 5
    Carlo Selmi, Ian R. Mackay, M. Eric Gershwin, The Autoimmune Diseases, 2014,

    CrossRef

  6. 6
    Carlo Selmi, Angela Ceribelli, M. Eric Gershwin, Autoantibodies, 2014,

    CrossRef

  7. 7
    Jun Shimizu, Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies, Rinsho Shinkeigaku, 2013, 53, 11, 1114

    CrossRef

  8. 8
    Masanobu Tsuda, Weici Zhang, Guo-Xiang Yang, Koichi Tsuneyama, Yugo Ando, Kazuhito Kawata, Ogyi Park, Patrick S.C. Leung, Ross L. Coppel, Aftab A. Ansari, William M. Ridgway, Bin Gao, Zhe-Xiong Lian, Richard Flavell, Xiao-Song He, M.Eric Gershwin, Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice, Hepatology, 2013, 57, 2
  9. 9
    Lu Wang, Jingbo Wang, Yongquan Shi, Xinmin Zhou, Xuechang Wang, Zengshan Li, Xiaofeng Huang, Jianhong Wang, Zheyi Han, Tingting Li, Min Wang, Ruian Wang, Daiming Fan, Ying Han, Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2, Journal of Proteomics, 2013, 91, 569

    CrossRef

  10. 10
    Fahad M. Khan, Arathi Rajendra Komarla, Paulo G. Mendoza, Henry C. Bodenheimer, Neil D. Theise, Keratin 19 demonstration of canal of hering loss in primary biliary cirrhosis: “Minimal Change PBC”?, Hepatology, 2013, 57, 2
  11. 11
    Pietro Invernizzi, Maria Alessio, Daniel S Smyk, Ana Lleo, Aurelio Sonzogni, Luca Fabris, Manila Candusso, Dimitrios P Bogdanos, Raffaele Iorio, Giuliano Torre, Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature, BMC Gastroenterology, 2012, 12, 1, 92

    CrossRef

  12. 12
    Man Li, Hao Zheng, Tao Li, Ping Gao, Xiao-Lin Zhang, Dian-Wu Liu, Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: A systematic review, Journal of Gastroenterology and Hepatology, 2012, 27, 7
  13. 13
    M. H. Maeda, S. Tsuji, J. Shimizu, Inflammatory myopathies associated with anti-mitochondrial antibodies, Brain, 2012, 135, 6, 1767

    CrossRef

  14. 14
    Nicola Bizzaro, Giovanni Covini, Floriano Rosina, Paolo Muratori, Elio Tonutti, Danilo Villalta, Fiorenza Pesente, Maria Grazia Alessio, Marilina Tampoia, Antonio Antico, Stefan Platzgummer, Brunetta Porcelli, Lucia Terzuoli, Marco Liguori, Danila Bassetti, Ignazio Brusca, Piero L. Almasio, Giuseppe Tarantino, Chiara Bonaguri, Paolo Agostinis, Elena Bredi, Renato Tozzoli, Pietro Invernizzi, Carlo Selmi, Overcoming a “Probable” Diagnosis in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis: Study of 100 Sera and Review of the Literature, Clinical Reviews in Allergy & Immunology, 2012, 42, 3, 288

    CrossRef

  15. 15
    Andreas L. Koutsoumpas, Stephen Kriese, Eirini I. Rigopoulou, Popular and unpopular infectious agents linked to primary biliary cirrhosis, Autoimmunity Highlights, 2012, 3, 3, 95

    CrossRef

  16. 16
    Yinon Shapira, Nancy Agmon-Levin, Yves Renaudineau, Bat Sheva Porat-Katz, Ori Barzilai, Maya Ram, Pierre Youinou, Yehuda Shoenfeld, Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden, Experimental and Molecular Pathology, 2012, 93, 3, 386

    CrossRef

  17. 17
    Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus, The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis, Clinical Reviews in Allergy & Immunology, 2012, 43, 3, 230

    CrossRef

  18. 18
    S. Shimoda, K. Tsuneyama, K. Kikuchi, K. Harada, Y. Nakanuma, M. Nakamura, H. Ishibashi, S. Hisamoto, H. Niiro, P. S. C. Leung, A. A. Ansari, M. E. Gershwin, K. Akashi, The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis, Clinical & Experimental Immunology, 2012, 168, 3
  19. 19
    M. Kay Washington, Michael P. Manns, MacSween's Pathology of the Liver, 2012,

    CrossRef

  20. 20
    Amy Dhirapong, Ana Lleo, Guo-Xiang Yang, Koichi Tsuneyama, Robert Dunn, Marilyn Kehry, Thomas A. Packard, John C. Cambier, Fu-Tong Liu, Keith Lindor, Ross L. Coppel, Aftab A. Ansari, M. Eric Gershwin, B cell depletion therapy exacerbates murine primary biliary cirrhosis, Hepatology, 2011, 53, 2
  21. 21
    Dimitrios P. Bogdanos, Lars Komorowski, Disease-specific autoantibodies in primary biliary cirrhosis, Clinica Chimica Acta, 2011, 412, 7-8, 502

    CrossRef

  22. 22
    Guanghua Rong, Renqian Zhong, Ana Lleo, Patrick S.C. Leung, Christopher L. Bowlus, Guo-Xiang Yang, Chen-Yen Yang, Ross L. Coppel, Aftab A. Ansari, Dean A. Cuebas, Howard J. Worman, Pietro Invernizzi, Gregory J. Gores, Gary Norman, Xiao-Song He, M. Eric Gershwin, Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis, Hepatology, 2011, 54, 1
  23. 23
    Carlo Selmi, Christopher L Bowlus, M Eric Gershwin, Ross L Coppel, Primary biliary cirrhosis, The Lancet, 2011, 377, 9777, 1600

    CrossRef

  24. 24
    Y. M. Ambrosini, G.-X. Yang, W. Zhang, M. Tsuda, S. Shu, K. Tsuneyama, P. S. C. Leung, A. A. Ansari, R. L. Coppel, M. E. Gershwin, The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis, Clinical & Experimental Immunology, 2011, 166, 1
  25. 25
    Nancy Agmon-Levin, Yinon Shapira, Carlo Selmi, Ori Barzilai, Maya Ram, Martine Szyper-Kravitz, Sara Sella, Bat-sheva Porat Katz, Pierre Youinou, Yves Renaudineau, Bruno Larida, Pietro Invernizzi, M. Eric Gershwin, Yehuda Shoenfeld, A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis, Journal of Autoimmunity, 2010, 34, 1, 55

    CrossRef

  26. 26
    Marina G. Silveira, Elizabeth M. Brunt, Jenny Heathcote, Gregory J. Gores, Keith D. Lindor, Marlyn J. Mayo, American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis, Hepatology, 2010, 52, 1
  27. 27
    Satoru Joshita, Takeji Umemura, Kaname Yoshizawa, Yoshihiko Katsuyama, Eiji Tanaka, Minoru Nakamura, Hiromi Ishibashi, Masao Ota, Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients, Journal of Hepatology, 2010, 53, 3, 537

    CrossRef

  28. 28
    Haiying Liu, Gary L. Norman, Zakera Shums, Howard J. Worman, Edward L. Krawitt, Nicola Bizzaro, Diego Vergani, Dimitrios P. Bogdanos, George N. Dalekos, Piotr Milkiewicz, Albert J. Czaja, E. Jenny Heathcote, Gideon M. Hirschfield, Eng M. Tan, Kiyomitsu Miyachi, Monica Bignotto, Pier Maria Battezzati, Ana Lleo, Patrick S. Leung, Mauro Podda, M. Eric Gershwin, Pietro Invernizzi, PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis, Journal of Autoimmunity, 2010, 35, 4, 436

    CrossRef

  29. 29
    C. Bossu Estour, M. Guillaume, F. Sarrot Reynauld, P.E. Rouge, L. Bouillet, C. Massot, L. Fardet, Une histoire de sucre bien salée, La Revue de Médecine Interne, 2010, 31, 3, 243

    CrossRef

  30. 30
    Ana Lleo, Carlo Selmi, Pietro Invernizzi, Mauro Podda, Ross L. Coppel, Ian R. Mackay, Gregory J. Gores, Aftab A. Ansari, Judy Van de Water, M. Eric Gershwin, Apotopes and the biliary specificity of primary biliary cirrhosis, Hepatology, 2009, 49, 3
  31. 31
    Toshihiro Kawai, Naomi Hosoya, Yuki Moritoki, Yusuke Kajiyama, Masashi Watanabe, Atsuko Takai, Carlo Selmi, M. Eric Gershwin, Hiroshi Miyakawa, Kentaro Kikuchi, Autoantibody IgG subclasses to recombinant antigens and the role of bacterial stimuli in primary biliary cirrhosis, Hepatology Research, 2009, 39, 9
  32. 32
    Ersan Ozaslan, Autoimmune hepatitis–autoimmune cholangitis overlap syndrome and autoimmune thyroiditis in a patient with celiac disease, European Journal of Gastroenterology & Hepatology, 2009, 21, 6, 716

    CrossRef

  33. 33
    Keith D. Lindor, M. Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V. Bergasa, E. Jenny Heathcote, Primary biliary cirrhosis, Hepatology, 2009, 50, 1
  34. 34
    Kentaro Kikuchi, Willy Hsu, Naomi Hosoya, Yuki Moritoki, Yusuke Kajiyama, Toshihiro Kawai, Atsuko Takai, Eriko Hayami, Carlo Selmi, M. Eric Gershwin, Hiroshi Miyakawa, Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis, Hepatology Research, 2009, 39, 5
  35. 35
    Piotr Milkiewicz, Hayman Buwaneswaran, Catalina Coltescu, Zakera Shums, Gary L. Norman, E. Jenny Heathcote, Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease, Clinical Gastroenterology and Hepatology, 2009, 7, 12, 1355

    CrossRef

  36. 36
    M. KAY WASHINGTON, Modern Surgical Pathology, 2009,

    CrossRef

  37. 37
    Carlo Selmi, Massimo Zuin, Christopher L. Bowlus, M. Eric Gershwin, Anti-Mitochondrial Antibody–Negative Primary Biliary Cirrhosis, Clinics in Liver Disease, 2008, 12, 1, 173

    CrossRef

  38. 38
    Luigi Muratori, Alessandro Granito, Paolo Muratori, Georgios Pappas, Francesco B. Bianchi, Antimitochondrial Antibodies and Other Antibodies in Primary Biliary Cirrhosis: Diagnostic and Prognostic Value, Clinics in Liver Disease, 2008, 12, 2, 261

    CrossRef

  39. 39
    Gideon M. Hirschfield, E.J. Heathcote, Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis, Clinics in Liver Disease, 2008, 12, 2, 323

    CrossRef

  40. 40
    Shinji Shimoda, Hiroshi Miyakawa, Minoru Nakamura, Hiromi Ishibashi, Kentaro Kikuchi, Hiroto Kita, Hiroaki Niiro, Youjirou Arinobu, Nobuyuki Ono, Ian R. Mackay, M. Eric Gershwin, Koichi Akashi, CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis, Journal of Autoimmunity, 2008, 31, 2, 110

    CrossRef

  41. 41
    I. Bargou, A. Mankaï, A. Jamaa, I. Ben Jazia, K. Skandrani, H. Sfar, A. Baccouche, S. Ajmi, A. Letaief, N. Fabien, M. Jeddi, I. Ghedira, Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay, Pathologie Biologie, 2008, 56, 1, 10

    CrossRef

  42. 42
    Eirini I Rigopoulou, George N Dalekos, Molecular diagnostics of primary biliary cirrhosis, Expert Opinion on Medical Diagnostics, 2008, 2, 6, 621

    CrossRef

  43. 43
    Carlo Selmi, Massimo Zuin, M. Eric Gershwin, The unfinished business of primary biliary cirrhosis, Journal of Hepatology, 2008, 49, 3, 451

    CrossRef

  44. 44
    Carlo Selmi, Michael P. Manns, M. Eric Gershwin, Clinical Immunology, 2008,

    CrossRef

  45. 45
    Sabine Oertelt, Roman Rieger, Carlo Selmi, Pietro Invernizzi, Aftab A. Ansari, Ross L. Coppel, Mauro Podda, Patrick S.C. Leung, M. Eric Gershwin, A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis, Hepatology, 2007, 45, 3
  46. 46
    Patrick S. C. Leung, Lorenzo Rossaro, Paul A. Davis, Ogyi Park, Atsushi Tanaka, Kentaro Kikuchi, Hiroshi Miyakawa, Gary L. Norman, William Lee, M. Eric Gershwin, Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis, Hepatology, 2007, 46, 5
  47. 47
    Mary K Washington, Autoimmune liver disease: overlap and outliers, Modern Pathology, 2007, 20, 1s, S15

    CrossRef

  48. 48
    Fumio Sakauchi, Asae Oura, Hirofumi Ohnishi, Mitsuru Mori, Comparison of the Clinical Features of Japanese Patients with Primary Biliary Cirrhosis in 1999 and 2004: Utilization of Clinical Data When Patients Applied to Receive Public Financial Aid, Journal of Epidemiology, 2007, 17, 6, 210

    CrossRef

  49. 49
    Eriko Iwasawa, Hiroshi Miyakawa, Kentaro Kikuchi, Akiko Nimi, Masako Hara, Naoyuki Kamatani, Detection and significance of anti-mitochondrial antibody in various collagen diseases, Kanzo, 2007, 48, 5, 210

    CrossRef

  50. 50
    Stella Gabeta, Gary L. Norman, Christos Liaskos, Panagiotis A. Papamichalis, Theodoros Zografos, Athanasios Garagounis, Eirini I. Rigopoulou, George N. Dalekos, Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis, Journal of Clinical Immunology, 2007, 27, 4, 378

    CrossRef

  51. 51
    Howard J. Worman, Nuclear envelope protein autoantigens in primary biliary cirrhosis, Hepatology Research, 2007, 37,
  52. 52
    Pietro Invernizzi, Carlo Selmi, M. Eric Gershwin, Autoantibodies, 2007,

    CrossRef

  53. 53
    Pierluigi Toniutto, Carlo Fabris, Mario Pirisi, Antiviral treatment of hepatitis C, Expert Opinion on Pharmacotherapy, 2006, 7, 15, 2025

    CrossRef

  54. 54
    Józefa Wesierska-Gadek, Edward Penner, Pier Maria Battezzati, Carlo Selmi, Massimo Zuin, Eva Hitchman, Howard J. Worman, M. Eric Gershwin, Mauro Podda, Pietro Invernizzi, Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis, Hepatology, 2006, 43, 5
  55. 55
    Christoph P. Berg, Gerburg M. Stein, Reinhild Klein, Maria Pascu, Thomas Berg, Winfried Kammer, Martin Priemer, Alfred Nordheim, Klaus Schulze-Osthoff, Michael Gregor, Sebastian Wesselborg, Peter A. Berg, Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients, Liver International, 2006, 26, 7
  56. 56
    Ruth Y. Lan, Chunmei Cheng, Zhe-Xiong Lian, Koichi Tsuneyama, Guo-Xiang Yang, Yuki Moritoki, Ya-Hui Chuang, Takafumi Nakamura, Shigeru Saito, Shinji Shimoda, Atsushi Tanaka, Christopher L. Bowlus, Yasuo Takano, Aftab A. Ansari, Ross L. Coppel, M. Eric Gershwin, Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis, Hepatology, 2006, 43, 4
  57. 57
    Saeko Nezu, Atsushi Tanaka, Hideaki Yasui, Makiko Imamura, Hiroshi Nakajima, Hitoshi Ishida, Shin-Ichi Takahashi, Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis, Journal of Gastroenterology and Hepatology, 2006, 21, 9
  58. 58
    Norihito Watanabe, Shinji Takashimizu, Koichi Shiraishi, Tetehiro Kagawa, Yasuhiro Nishizaki, Tetsuya Mine, Akira Akatsuka, Carlo Selmi, M. Eric Gershwin, Primary biliary cirrhosis with multinucleated hepatocellular giant cells: implications for pathogenesis of primary biliary cirrhosis, European Journal of Gastroenterology & Hepatology, 2006, 18, 9, 1023

    CrossRef

  59. 59
    Carlo Selmi, Ross L. Coppel, M. Eric Gershwin, The Autoimmune Diseases, 2006,

    CrossRef

  60. 60
    Hiroki HASUI, Koutarou NISHIMURA, Akira IZUMORI, Yositeru KAJI, Akira SATOU, A case of primary biliary cirrhosis seronegative for anti-nuclear, anti-mitochodrial antibodies but positive for anti-smooth muscle antibody, Kanzo, 2005, 46, 9, 563

    CrossRef

  61. 61
    Kentaro Kikuchi, Zhe-Xiong Lian, Guo-Xiang Yang, Aftab A. Ansari, Susumu Ikehara, Marshall Kaplan, Hiroshi Miyakawa, Ross L. Coppel, M. Eric Gershwin, Bacterial CpG induces hyper-IgM production in CD27+ memory B cells in primary biliary cirrhosis, Gastroenterology, 2005, 128, 2, 304

    CrossRef

  62. 62
    C Selmi, P Invernizzi, M Zuin, M Podda, M F Seldin, M E Gershwin, Genes and (auto)immunity in primary biliary cirrhosis, Genes and Immunity, 2005, 6, 7, 543

    CrossRef

  63. 63
    Kentaro Kikuchi, Zhe-Xiong Lian, Yasuhiko Kimura, Carlo Selmi, Guo-Xiang Yang, Stuart C. Gordon, Pietro Invernizzi, Mauro Podda, Ross L. Coppel, Aftab A. Ansari, Susumu Ikehara, Hiroshi Miyakawa, M. Eric Gershwin, Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis, Journal of Autoimmunity, 2005, 24, 4, 347

    CrossRef

  64. 64
    Ulrich Beuers, Hepatic overlap syndromes, Journal of Hepatology, 2005, 42, 1, S93

    CrossRef

  65. 65
    Ya-Hui Chuang, Zhe-Xiong Lian, Chun-Mei Cheng, Ruth Y. Lan, Guo-Xiang Yang, Yuki Moritoki, Bor-Luen Chiang, Aftab A. Ansari, Koichi Tsuneyama, Ross L. Coppel, M. Eric Gershwin, Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives, Journal of Autoimmunity, 2005, 25, 2, 126

    CrossRef

  66. 66
    ALESSIA GIORGINI, CARLO SELMI, PIETRO INVERNIZZI, M.URO PODDA, M.SSIMO ZUIN, M.ERIC GERSHWIN, Primary Biliary Cirrhosis: Solving the Enigma, Annals of the New York Academy of Sciences, 2005, 1051, 1
  67. 67
    M. Eric Gershwin, Carlo Selmi, Howard J. Worman, Ellen B. Gold, Mitchell Watnik, Jessica Utts, Keith D. Lindor, Marshall M. Kaplan, John M. Vierling, Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients, Hepatology, 2005, 42, 5
  68. 68
    Sabine Oertelt, Thomas P. Kenny, Carlo Selmi, Pietro Invernizzi, Mauro Podda, M. Eric Gershwin, SNP Analysis of Genes Implicated in T Cell Proliferation in Primary Biliary Cirrhosis, Clinical and Developmental Immunology, 2005, 12, 4, 259

    CrossRef

  69. 69
    R. Moreno-Otero, Therapeutic modalities in hepatitis C: challenges and development, Journal of Viral Hepatitis, 2005, 12, 1
  70. 70
    Albert J. Czaja, 2005,

    CrossRef

  71. 71
    Sigurdur Olafsson, Hallgrimur Gudjonsson, Carlo Selmi, Katsushi Amano, Pietro Invernizzi, Mauro Podda, M. Eric Gershwin, Antimitochondrial Antibodies and Reactivity to N. Aromaticivorans Proteins in Icelandic Patients with Primary Biliary Cirrhosis and Their Relatives, The American Journal of Gastroenterology, 2004, 99, 11, 2143

    CrossRef

  72. 72
    G. V. Papatheodoridis, E. Cholongitas, Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options, Journal of Viral Hepatitis, 2004, 11, 4
  73. 73
    Paul J. Pockros, Current status of immunomodulatory therapies in HCV infection, Current Hepatitis Reports, 2004, 3, 1, 16

    CrossRef

  74. 74
    Pierre Deltenre, Jean Henrion, Valérie Canva, Sebastien Dharancy, Frédéric Texier, Alexandre Louvet, Stephane De Maeght, Jean-Claude Paris, Philippe Mathurin, Evaluation of amantadine in chronic hepatitis C: a meta-analysis, Journal of Hepatology, 2004, 41, 3, 462

    CrossRef

  75. 75
    Takashi Kato, Hiroshi Miyakawa, Miyuki Ishibashi, Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis, Journal of Autoimmunity, 2004, 22, 3, 211

    CrossRef

  76. 76
    Carlo Selmi, Susan R. Ross, Aftab A. Ansari, Pietro Invernizzi, Mauro Podda, Ross L. Coppel, M.Eric Gershwin, Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology, 2004, 127, 2, 493

    CrossRef

  77. 77
    Anouk Dev, Keyur Patel, John G. McHutchison, New therapies for chronic hepatitis C virus infection, Current Gastroenterology Reports, 2004, 6, 1, 77

    CrossRef

  78. 78
    Manuel Romero-Gomez, Ingeborg Wichmann, Javier Crespo, Albert Pares, Luis Rodrigo, Antonia Alvarez, Moises Diago, Fernando Pons-Romero, Diego Sanchez-Munoz, Jose Aguilar-Reina, Raul J. Andrade, Javier Salmeron, Pilar Sanchez-Pobre, Jaime M. Rebollo, Rafael Martin-Vivaldi, Victor Castellano-Megias, Antonio Nunez-Roldan, Miquel Bruguera, Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis, The American Journal of Gastroenterology, 2004, 99, 11, 2150

    CrossRef

  79. 79
    Dimitrios-Petrou Bogdanos, Harold Baum, Diego Vergani, Antimitochondrial and other autoantibodies, Clinics in Liver Disease, 2003, 7, 4, 759

    CrossRef

  80. 80
    Howard J Worman, Jean-Claude Courvalin, Antinuclear antibodies specific for primary biliary cirrhosis, Autoimmunity Reviews, 2003, 2, 4, 211

    CrossRef

  81. 81
    Albert J. Czaja, Gary L. Norman, Autoantibodies in the Diagnosis and Management of Liver Disease, Journal of Clinical Gastroenterology, 2003, 37, 4, 315

    CrossRef

  82. 82
    Yoshiko Kadokawa, Katsuhisa Omagari, Hiroaki Hazama, Kazuo Ohba, Jun-ichi Masuda, Hideki Kinoshita, Kenji Hayashida, Hajime Isomoto, Yohei Mizuta, Kunihiko Murase, Ikuo Murata, Shigeru Kohno, Evaluation of newly developed ELISA using “MESACUP-2 test mitochondrial M2” kit for the diagnosis of primary biliary cirrhosis, Clinical Biochemistry, 2003, 36, 3, 203

    CrossRef

  83. 83
    J. P. Gisbert, E. A. Jones, J. M. Pajares, R. Moreno-Otero, Is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?, Alimentary Pharmacology & Therapeutics, 2003, 17, 1
  84. 84
    Marlyn J Mayo, Primary biliary cirrhosis: the future, Clinics in Liver Disease, 2003, 7, 4, 957

    CrossRef

  85. 85
    Kiyomitsu Miyachi, Raleigh W. Hankins, Hiroshi Matsushima, Futoshi Kikuchi, Tetushi Inomata, Tuneyoshi Horigome, Minoru Shibata, Yasushi Onozuka, Yukihisa Ueno, Etsuko Hashimoto, Naoaki Hayashi, Akitaka Shibuya, Shuichi Amaki, Hiroshi Miyakawa, Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study, Journal of Autoimmunity, 2003, 20, 3, 247

    CrossRef

  86. 86
    E. Jenny Heathcote, Treatment Considerations in Patients With Hepatitis C and Cirrhosis, Journal of Clinical Gastroenterology, 2003, 37, 5, 395

    CrossRef

  87. 87
    Todd E. Dantzler, Eric J. Lawitz, Treatment of chronic hepatitis C in nonresponders to previous therapy, Current Gastroenterology Reports, 2003, 5, 1, 78

    CrossRef

  88. 88
    Mazen Alsatie, Paul Y. Kwo, Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy, Current Hepatitis Reports, 2003, 2, 1, 32

    CrossRef

  89. 89
    Marvin J Fritzler, Michael P Manns, Anti-mitochondrial autoantibodies, Clinical and Applied Immunology Reviews, 2002, 3, 3, 87

    CrossRef

  90. 90
    James Neuberger, Antibodies and primary biliary cirrhosis – piecing together the jigsaw, Journal of Hepatology, 2002, 36, 1, 126

    CrossRef

  91. 91
    Albert J. Czaja, Autoimmune liver disease, Current Opinion in Gastroenterology, 2002, 18, 3, 334

    CrossRef

  92. 92
    HIROAKI HAZAMA, KATSUHISA OMAGARI, JUN-ICHI MASUDA, KAZUO OHBA, HIDEKI KINOSHITA, ISAO MATSUO, HAJIME ISOMOTO, YOHEI MIZUTA, KUNIHIKO MURASE, IKUO MURATA, SHIGERU KOHNO, Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: Applications of a routine diagnostic tool for the detection of antimitochondrial antibodies, Journal of Gastroenterology and Hepatology, 2002, 17, 3
  93. 93
    Michael Trauner, James L. Boyer, Cholestatic syndromes, Current Opinion in Gastroenterology, 2002, 18, 3, 314

    CrossRef

  94. 94
    Paul J Pockros, Developments in the treatment of chronic hepatitis C, Expert Opinion on Investigational Drugs, 2002, 11, 4, 515

    CrossRef

  95. 95
    John G. McHutchison, Keyur Patel, Future therapy of hepatitis C, Hepatology, 2002, 36, S1
  96. 96
    Julianne Stone, Judy A Wade, Karen Cauch-Dudek, Chang Ng, Keith D Lindor, E.Jenny Heathcote, Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis, Journal of Hepatology, 2002, 36, 1, 8

    CrossRef

  97. 97
    Markus Cornberg, Holger Hinrichsen, Gerlinde Teuber, Thomas Berg, Uta Naumann, Christian Falkenberg, Stefan Zeuzem, Michael P Manns, Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C, Journal of Hepatology, 2002, 37, 6, 843

    CrossRef

  98. 98
    Alastair D Burt, Primary biliary cirrhosis and other ductopenic diseases, Clinics in Liver Disease, 2002, 6, 2, 363

    CrossRef

  99. 99
    Herschel A Carpenter, Albert J Czaja, The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants, Clinics in Liver Disease, 2002, 6, 3, 685

    CrossRef

  100. 100
    Jenny Heathcote, Variant syndromes of autoimmune hepatitis, Clinics in Liver Disease, 2002, 6, 3, 669

    CrossRef

  101. 101
    James Neuberger, Arthur R Bradwell, Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis [Lancet 1965;i:827–831], Journal of Hepatology, 2002, 37, 6, 712

    CrossRef